will mochi stop selling tirzepatide Health Jennifer - Well it's been

Food and Drug Administration approved the semaglutide injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity

PlexusDx connects patients directly to licensed compounding pharmacies that formulate personalized semaglutide injections without requiring insurance or membership fees

## **What is a receiver (monitor) external for a non-durable interstitial CGM system?** HCPCS code A9278 is used to report when a patient is provided with an external receiver (monitor) that works with a non-durable medical equipment continuous glucose monitoring (CGM) system

Dietary Iodine Content Papillary thyroid cancer occurs with higher frequency in regions where dietary iodine content is low

Understanding the Side Effects Both Semaglutide and Tirzepatide are generally well-tolerated, with similar side effect profiles: Gastrointestinal Symptoms: Common side effects for both medications include nausea, vomiting, and diarrhea, particularly when starting treatment